161
Participants
Start Date
November 24, 2021
Primary Completion Date
July 19, 2023
Study Completion Date
April 23, 2024
rilzabrutinib
Tablet, oral use
placebo
Tablet, oral use
Investigational Site Number :1580003, Taichung
Investigational Site Number : 1580004, Kaohsiung City
Investigational Site Number :1580004, Kaohsiung City
Investigational Site Number : 0320004, Rosario
Investigational Site Number : 0320005, Rosario
Investigational Site Number :0320004, Rosario
Investigational Site Number :0320005, Rosario
Investigational Site Number : 1580001, Taipei
Investigational Site Number :1580001, Taipei
Investigational Site Number :2760002, Berlin
Investigational Site Number : 2760002, Berlin
Investigational Site Number : 3000001, Athens
Investigational Site Number :3000001, Athens
Investigational Site Number : 7240002, Córdoba
Investigational Site Number :7240002, Córdoba
Investigational Site Number : 4100005, Ansan-si
Investigational Site Number :4100005, Ansan-si
Investigational Site Number : 3000002, Athens
Investigational Site Number :3000002, Athens
Investigational Site Number : 3800001, Milan
Investigational Site Number :3800001, Milan
Investigational Site Number :3800004, Milan
Investigational Site Number : 2760005, Kiel
Investigational Site Number :2760005, Kiel
Investigational Site Number :7240007, Pozuelo de Alarcón
Investigational Site Number : 1580002, Hsinchu
Investigational Site Number :1580002, Hsinchu
Investigational Site Number : 7240006, Pamplona
Investigational Site Number :7240003, Pamplona
Investigational Site Number :7240006, Pamplona
Investigational Site Number : 1580003, Taichung
Investigational Site Number : 7240004, Seville
Investigational Site Number :7240004, Seville
Investigational Site Number : 4100002, Busan
Investigational Site Number : 2760004, Mainz
Investigational Site Number :2760004, Mainz
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 3000004, N. Efkarpia
Investigational Site Number :3000004, N. Efkarpia
Investigational Site Number :3000003, Thessaloniki
Investigational Site Number : 3800002, Ancona
Investigational Site Number :3800002, Ancona
Investigational Site Number : 6430005, Moscow
Investigational Site Number :6430005, Moscow
Investigational Site Number :6430006, Moscow
Investigational Site Number : 6430002, Moscow
Investigational Site Number :6430002, Moscow
Investigational Site Number :6430003, Saint Petersburg
Investigational Site Number :6430004, Smolensk
Investigational Site Number : 6430001, Stavropol
Investigational Site Number :6430001, Stavropol
Investigational Site Number : 1520004, Osorno
Investigational Site Number :1520004, Osorno
Investigational Site Number : 1520001, Santiago
Investigational Site Number :1520001, Santiago
Investigational Site Number :1520003, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 0320006, CABA
Investigational Site Number :0320006, CABA
Investigational Site Number : 0320002, CABA
Investigational Site Number :0320002, CABA
Investigational Site Number : 0320003, Rosario
Investigational Site Number :0320003, Rosario
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number :0320001, Buenos Aires
Investigational Site Number :1240010, Calgary
Investigational Site Number : 1240009, Red Deer
Investigational Site Number :1240009, Red Deer
Investigational Site Number : 1240005, Toronto
Investigational Site Number :1240005, Toronto
Investigational Site Number : 1240004, Toronto
Investigational Site Number :1240004, Toronto
Investigational Site Number : 1240006, Montreal
Investigational Site Number :1240006, Montreal
Investigational Site Number : 1240002, Trois-Rivières
Investigational Site Number :1240002, Trois-Rivières
Investigational Site Number : 1240003, Québec
Investigational Site Number :1240003, Québec
Investigational Site Number :1520002, Santiago
Investigational Site Number : 3800005, Catania
Investigational Site Number :3800005, Catania
Investigational Site Number : 2760001, Dresden
Investigational Site Number :2760001, Dresden
Investigational Site Number :3920004, Nagoya
Investigational Site Number : 3920004, Nagoya
Investigational Site Number : 3920005, Chikushino-shi
Investigational Site Number :3920005, Chikushino-shi
Investigational Site Number : 3920002, Sapporo
Investigational Site Number :3920002, Sapporo
Investigational Site Number : 3920001, Sagamihara-shi
Investigational Site Number :3920001, Sagamihara-shi
Investigational Site Number : 3920007, Yokohama
Investigational Site Number :3920007, Yokohama
Investigational Site Number : 3920006, Izumo-shi
Investigational Site Number :3920006, Izumo-shi
Investigational Site Number : 3920003, Tachikawa-shi
Investigational Site Number :3920003, Tachikawa-shi
Investigational Site Number : 5280002, Rotterdam
Investigational Site Number :5280002, Rotterdam
Investigational Site Number : 5280001, Utrecht
Investigational Site Number :5280001, Utrecht
Investigational Site Number :6160007, Wroclaw
Investigational Site Number : 6160007, Wroclaw
Investigational Site Number : 6160001, Gdansk
Investigational Site Number :6160001, Gdansk
Investigational Site Number : 6160009, Gdansk
Investigational Site Number :6160009, Gdansk
Investigational Site Number : 6160008, Krakow
Investigational Site Number :6160008, Krakow
Investigational Site Number : 6160004, Krakow
Investigational Site Number :6160004, Krakow
Investigational Site Number :6160003, Krakow
Investigational Site Number : 6160005, Lodz
Investigational Site Number :6160005, Lodz
Investigational Site Number : 6160006, Wroclaw
Investigational Site Number :6160006, Wroclaw
Investigational Site Number :4100002, Busan
Investigational Site Number :4100001, Seoul
Investigational Site Number : 4100003, Seoul
Investigational Site Number :4100003, Seoul
Investigational Site Number : 4100004, Yeongdeunpo-gu
Investigational Site Number :4100004, Yeongdeunpo-gu
Investigational Site Number : 7240001, Barcelona
Investigational Site Number :7240001, Barcelona
Investigational Site Number : 7240008, Barcelona / Sabadell
Investigational Site Number :7240008, Barcelona / Sabadell
Investigational Site Number : 7240005, Alicante
Investigational Site Number :7240005, Alicante
Lead Sponsor
Sanofi
INDUSTRY